Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that works by regulating hunger signals in the brain and slowing stomach emptying, helping patients lose an average of 15-22% of body weight. The medication is given as a once-weekly injection that follows a specific titration schedule, beginning at a low dose and increasing every four weeks until reaching your therapeutic dose. Understanding how this schedule works helps patients prepare for their weight loss journey and set realistic expectations.
Understanding the Weekly Semaglutide Injection Schedule
Semaglutide injections are administered once per week on the same day, making adherence straightforward and predictable. The standard titration protocol begins at 0.25 mg weekly for the first month, then increases to 0.5 mg in week five, continuing upward through week 16 when most patients reach their maintenance dose of 2.0-2.4 mg. This gradual approach allows your body to adapt to the medication while reducing gastrointestinal side effects that commonly occur when doses escalate too quickly.
The timing of your weekly injection doesn't need to be exact to the hour, but consistency helps establish a sustainable routine. Most patients choose the same day and time each week—such as Sunday morning—to integrate the injection into their existing schedule. PlexusDx's compounded semaglutide injection maintains the same evidence-based titration framework as brand-name medications, sourced from licensed 503A compounding pharmacies across all 50 states.
Semaglutide Titration: What to Expect Month by Month
Weeks 1-4 begin with the starter dose of 0.25 mg, often called the 'low-dose introduction' phase where your body develops tolerance and you may notice early appetite reduction. During weeks 5-8, the dose increases to 0.5 mg as your GLP-1 receptors become more responsive, and weight loss typically becomes noticeable during this window. By weeks 9-12, you'll reach 1.0 mg, and weeks 13-16 bring you to either 1.7 mg or 2.0-2.4 mg depending on your provider's clinical assessment and your individual response.
Some patients reach optimal weight loss and satisfaction at intermediate doses like 1.0 or 1.7 mg and may not require progression to the highest dose. Your prescriber monitors your progress, side effect tolerance, and weight loss trajectory throughout the titration schedule to determine if continuing upward is necessary. PlexusDx patients can discuss dose optimization with their care team and consider genetic insights from the Precision Peptide Genetic Test, which identifies variants in the GLP1R pathway that influence medication responsiveness.
Why Weekly Dosing Works Better Than Daily Options
Weekly semaglutide injections maintain more stable blood levels compared to daily oral formulations, reducing the risk of sharp appetite suppression swings that can cause nausea or medication fatigue. The extended-release formulation in injectable semaglutide allows a single dose to work throughout the seven-day period, which improves compliance and reduces the chance of missed doses that can reset progress. Research shows that weekly injection regimens produce more consistent weight loss patterns and higher patient satisfaction than daily alternatives.
Injectable semaglutide also reaches the bloodstream faster than oral tablets, which must pass through stomach acid and require specific fasting conditions for absorption. The bioavailability advantage of injection means you experience more predictable appetite suppression starting within hours of your weekly dose, creating reliable behavioral patterns around eating and hunger cues. For patients seeking maximum efficacy and minimal variation, PlexusDx's compounded semaglutide injection starting at $149 per month offers the clinical benefits of weekly dosing without the premium brand price.
Personalizing Your Semaglutide Schedule: Genetic and Clinical Factors
Individual genetics significantly influence how your body responds to semaglutide dosing schedules, particularly variants in the GLP1R gene (rs6923761) that affect receptor sensitivity and peptide binding efficiency. The PlexusDx Precision Peptide Genetic Test identifies your unique genetic profile across 14 pathways and 150+ insights, helping your provider predict whether you'll respond optimally at standard doses or may benefit from dose adjustments earlier in your titration. Patients with higher-sensitivity GLP1R variants may achieve target weight loss at lower doses, reducing overall side effects and treatment costs.
Beyond genetics, clinical factors like baseline weight, metabolic rate, prior medication history, and gastrointestinal tolerance shape your ideal semaglutide schedule. Some patients with rapid metabolism or higher baseline weights progress steadily through the full 16-week titration, while others experience excellent results and stabilize at intermediate doses around week 12. PlexusDx providers review both genetic data and clinical markers to create personalized dosing timelines that maximize safety and efficacy for each patient.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take semaglutide more than once per week?
No, semaglutide is designed specifically as a once-weekly injection and should never be taken more frequently. Taking extra doses increases the risk of severe side effects and provides no additional weight loss benefit. Always follow your prescriber's titration schedule and inject only on your designated weekly day.
What happens if I miss a weekly semaglutide injection?
If you miss your dose by a day or two, take it as soon as you remember and continue your regular schedule the following week. Missing more than two or three days can allow your appetite-suppressing effects to wear off temporarily, potentially triggering increased hunger. Establishing a consistent weekly routine—such as Sunday mornings—minimizes the chance of missed doses and maintains steady weight loss momentum.
Does semaglutide dosing change based on how much weight I lose?
Your dose typically continues on the standard titration schedule regardless of weight loss progress, though your provider may adjust timing based on side effects or clinical response. Some patients stabilize at lower doses once they reach desired weight, while others benefit from reaching the full 2.0-2.4 mg maintenance range. PlexusDx follows individualized clinical protocols and does not change monthly pricing based on dose adjustments—your price remains flat across all titration levels.
Is weekly semaglutide dosing safe for long-term use?
Yes, semaglutide has demonstrated safety in clinical trials lasting up to 68 weeks with consistent weekly dosing, showing sustained weight loss without increasing adverse event rates over time. Common side effects like nausea typically improve after the first 4-8 weeks as your body adapts. Your PlexusDx provider monitors your safety through regular check-ins and can adjust your dose or treatment plan if any concerns emerge.
How does PlexusDx's Precision Peptide Genetic Test improve my semaglutide dosing timeline?
The Precision Peptide Genetic Test identifies your GLP1R receptor variants and other genetic factors that influence how quickly your body responds to dose increases and reaches optimal weight loss. Patients with favorable genetic markers may progress more efficiently through titration and stabilize at lower doses, while those with different variants might benefit from extended time at each dose level. The $99 test, available after your first month of treatment, provides personalized insights that help your provider optimize your exact dosing schedule.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Do Wegovy Side Effects Increase with Dosage? Exploring the Impacts
Navigating Your Diet: Do I Eat Before Taking Ozempic for Optimal Results?